New treatment option for Prostate Cancer
Official title Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program
ClinicalTrials.gov ID: NCT04895839
What this study is testing
- What it's testing
- Each year over 20,000 men are diagnosed with prostate cancer in Canada with the majority undergoing some form of treatment option. Radical prostatectomy and/or radiation therapy are common procedures that are effective in the treatment of prostate cancer.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only. Healthy volunteers may be eligible.
You may be able to join if
- Age \>18
- History of a prostate cancer diagnosis
- Safe to exercise and do strength training (participants who have recovered from a minor stroke or heart condition in the past will require approval...
- Existing (or willingness to create) email account
- Willingness to access and use daily email and/or text messages
You likely can't join if
- Patients deemed unfit to participate in low level exercise eg. including but not limited to a myocardial infarction or stroke within the last year...
- Unable to access the internet and lack of a computer or cellphone to receive emails required for study intervention, or unable to click on a link to...
- Men with a predicted survival less than 2 years.
See the full eligibility criteria
- Age \>18
- History of a prostate cancer diagnosis
- Safe to exercise and do strength training (participants who have recovered from a minor stroke or heart condition in the past will require approval from their Family Physician or Cardiologist to participate in the...
- Existing (or willingness to create) email account
- Willingness to access and use daily email and/or text messages
- Ability to follow website links to watch YouTube videos
- Ability to understand and speak English
- Ability to participate in low to moderate levels of physical activity
- Ability and willingness to fill out an online survey at baseline, and 6, 12 and 24 months, and a weekly compliance survey for the six months of the program.
- Deemed to have an expected survival greater than 2 years
- Patients deemed unfit to participate in low level exercise eg. including but not limited to a myocardial infarction or stroke within the last year, without approval from their Family Physician or Cardiologist that they...
- Unable to access the internet and lack of a computer or cellphone to receive emails required for study intervention, or unable to click on a link to successfully watch a YouTube video.
- Men with a predicted survival less than 2 years.
The study team makes the final eligibility decision.
Where it's taking place
- Ghent, East Flanders, Belgium
- Edmonton, Alberta, Canada
- Kelowna, British Columbia, Canada
- Winnipeg, Manitoba, Canada
- Saint John, New Brunswick, Canada
- St. John's, Newfoundland and Labrador, Canada
- Halifax, Nova Scotia, Canada
- Toronto, Ontario, Canada
- Whitby, Ontario, Canada
- Charlottetown, Prince Edward Island, Canada
- Québec, Quebec, Canada
- Saskatoon, Saskatchewan, Canada
- Auckland, New Zealand
- Cluj-Napoca, Transylvania, Romania
- Ga-Rankuwa, Gauteng, South Africa
- Johannesburg, Gauteng, South Africa
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ghent, East Flanders, Belgium; Edmonton, Alberta, Canada; Kelowna, British Columbia, Canada; Winnipeg, Manitoba, Canada; Saint John, New Brunswick, Canada; St. John's, Newfoundland and Labrador, Canada and 10 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.